Harvard Bioscience Inc.
HBIO
Market Cap$13.93M
Close$
$0.50
57.7% upside
Current Fair Value
57.7% upsideUndervalued by 57.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $13.93 Million |
|---|---|
| Enterprise Value | $9.82 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.28 |
| Beta | 1.45 |
| Outstanding Shares | 43,659,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.11 |
|---|---|
| PEG | -0.39 |
| Price to Sales | 0.16 |
| Price to Book Ratio | 0.16 |
| Enterprise Value to Revenue | 0.1 |
| Enterprise Value to EBIT | -1.97 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
ESG Score
No data